180 related articles for article (PubMed ID: 35454796)
1. Oestrogen Receptor Isoforms May Represent a Therapeutic Target in Oesophageal Adenocarcinoma.
Due SL; Watson DI; Bastian I; Eichelmann AK; Hussey DJ
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454796
[TBL] [Abstract][Full Text] [Related]
2. Oestrogen receptors: A potential therapeutic target in oesophageal adenocarcinoma?
Due SL; Watson DI; Hussey DJ
ANZ J Surg; 2021 Jul; 91(7-8):1390-1396. PubMed ID: 34227212
[TBL] [Abstract][Full Text] [Related]
3. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
Gougelet A; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen enhances the cytotoxicity of conventional chemotherapy in esophageal adenocarcinoma cells.
Due SL; Watson DI; Bastian I; Ding GQ; Sukocheva OA; Astill DS; Vat L; Hussey DJ
Surg Oncol; 2016 Sep; 25(3):269-77. PubMed ID: 27566033
[TBL] [Abstract][Full Text] [Related]
5. Probing the link between oestrogen receptors and oesophageal cancer.
Rashid F; Khan RN; Iftikhar SY
World J Surg Oncol; 2010 Feb; 8():9. PubMed ID: 20146809
[TBL] [Abstract][Full Text] [Related]
6. Modulating therapeutic effects of the c-Src inhibitor via oestrogen receptor and human epidermal growth factor receptor 2 in breast cancer cell lines.
Fan P; McDaniel RE; Kim HR; Clagett D; Haddad B; Jordan VC
Eur J Cancer; 2012 Dec; 48(18):3488-98. PubMed ID: 22658320
[TBL] [Abstract][Full Text] [Related]
7. Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER alpha and beta subtypes via an Sp1 site.
Salvatori L; Pallante P; Ravenna L; Chinzari P; Frati L; Russo MA; Petrangeli E
Oncogene; 2003 Jul; 22(31):4875-81. PubMed ID: 12894229
[TBL] [Abstract][Full Text] [Related]
8. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
Dardes RC; Schafer JM; Pearce ST; Osipo C; Chen B; Jordan VC
Gynecol Oncol; 2002 Jun; 85(3):498-506. PubMed ID: 12051881
[TBL] [Abstract][Full Text] [Related]
9. Identification of wild type and variants of oestrogen receptors in polymorphonuclear and mononuclear leucocytes.
Stygar D; Westlund P; Eriksson H; Sahlin L
Clin Endocrinol (Oxf); 2006 Jan; 64(1):74-81. PubMed ID: 16402932
[TBL] [Abstract][Full Text] [Related]
10. Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells.
Murphy LC; Peng B; Lewis A; Davie JR; Leygue E; Kemp A; Ung K; Vendetti M; Shiu R
J Mol Endocrinol; 2005 Apr; 34(2):553-66. PubMed ID: 15821116
[TBL] [Abstract][Full Text] [Related]
11. Influence of oestradiol and tamoxifen on oestrogen receptors-alpha and -beta protein degradation and non-genomic signalling pathways in uterine and breast carcinoma cells.
Horner-Glister E; Maleki-Dizaji M; Guerin CJ; Johnson SM; Styles J; White IN
J Mol Endocrinol; 2005 Dec; 35(3):421-32. PubMed ID: 16326830
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen exerts oestrogen-agonistic effects on proliferation and plasminogen activation, but not on gelatinase activity, glycogen metabolism and p53 protein expression, in cultures of oestrogen-responsive human endometrial adenocarcinoma cells.
Hochner-Celnikier D; Greenfield C; Finci-Yeheskel Z; Milwidsky A; Gutman A; Goldman-Wohl D; Yagel S; Mayer M
Mol Hum Reprod; 1997 Dec; 3(12):1019-27. PubMed ID: 9464846
[TBL] [Abstract][Full Text] [Related]
13. Oestrogen receptor ERα and ERβ agonists ameliorate oxidative brain injury and improve memory dysfunction in rats with an epileptic seizure.
Koyuncuoğlu T; Arabacı Tamer S; Erzik C; Karagöz A; Akakın D; Yüksel M; Yeğen BÇ
Exp Physiol; 2019 Dec; 104(12):1911-1928. PubMed ID: 31608530
[TBL] [Abstract][Full Text] [Related]
14. Changes in oestrogen receptor-alpha and -beta during progression to acquired resistance to tamoxifen and fulvestrant (Faslodex, ICI 182,780) in MCF7 human breast cancer cells.
Shaw LE; Sadler AJ; Pugazhendhi D; Darbre PD
J Steroid Biochem Mol Biol; 2006 Apr; 99(1):19-32. PubMed ID: 16533599
[TBL] [Abstract][Full Text] [Related]
15. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
[TBL] [Abstract][Full Text] [Related]
16. Oestrogen receptor beta and neoadjuvant therapy with tamoxifen: prediction of response and effects of treatment.
Miller WR; Anderson TJ; Dixon JM; Saunders PT
Br J Cancer; 2006 May; 94(9):1333-8. PubMed ID: 16622466
[TBL] [Abstract][Full Text] [Related]
17. Oestrogen receptor-regulated glutathione S-transferase mu 3 expression attenuates hydrogen peroxide-induced cytotoxicity, which confers tamoxifen resistance on breast cancer cells.
Lin JH; Tu SH; Chen LC; Huang CC; Chang HL; Cheng TC; Chang HW; Wu CH; Wu HC; Ho YS
Breast Cancer Res Treat; 2018 Nov; 172(1):45-59. PubMed ID: 30054830
[TBL] [Abstract][Full Text] [Related]
18. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
[TBL] [Abstract][Full Text] [Related]
19. Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha.
Collins F; MacPherson S; Brown P; Bombail V; Williams AR; Anderson RA; Jabbour HN; Saunders PT
BMC Cancer; 2009 Sep; 9():330. PubMed ID: 19758455
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-secreting cells in ovariectomized rats treated with different oestrogen receptor ligands: a modulatory role for ERbeta in the gonadotrope?
Sánchez-Criado JE; de Las Mulas JM; Bellido C; Navarro VM; Aguilar R; Garrido-Gracia JC; Malagón MM; Tena-Sempere M; Blanco A
J Endocrinol; 2006 Feb; 188(2):167-77. PubMed ID: 16461544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
